In early lung cancer, NF-κB plays an essential role in immune surveillance (Hopewell et al., 2013), and the activation of M1 macrophages is critical to inhibiting the progression of this disease (Singhal et al., 2019). This evidence concerns the gene NFKB1 and lung cancer.